Home | Join Now | Print Page | Report Abuse | Sign In
Online Store: On Demand Webinars
Main Storefront
        

Reducing Risk of Adverse Drug Events by Identifying Multi-Drug...

Item Options
Sign in for your pricing!
Price: $25.00
Quantity: *
 
Description

Reducing Risk of Adverse Drug Events by Identifying Multi-Drug, Simultaneous Interactions

Online Webinar

This webinar will describe the pervasiveness of multi-drug, simultaneous interactions and their influence on adverse drug events, especially in patients with polypharmacy. This webinar will also discuss how pharmacists and pharmacy technicians are uniquely positioned to identify and minimize these risks.

Upon completion of this activity, pharmacists should be able to:

  • Discuss the risk for multi-drug interactions associated with polypharmacy. 
  • Explain several medication risk mitigation concepts, including anticholinergic burden, competitive inhibition, and others. 
  • Apply principles of medication risk mitigation to a patient case scenario.

Upon completion of this activity, technicians should be able to:

  • Discuss the risk for multi-drug interactions associated with polypharmacy.
  • Explain several medication risk mitigation concepts, including anticholinergic burden, competitive inhibition, and others.
  • Apply principles of medication risk mitigation to a patient case scenario (for example, to help ask clarifying questions and identify potential risk for escalation).

Speaker

Calvin H. Knowlton, BScPharm, MDiv, PhD

Dr. Knowlton has won numerous awards for his leadership in pharmacy, business, and philanthropy in his career of over 35 years, including the 2003 & 2013 Ernst and Young Entrepreneur of the Year Award, Greater Philadelphia Region, and the 2016 Philadelphia Technology CEO of the year. He has served as the national President for the American College of Apothecaries, President of the American Pharmacists Association for two terms, and President of the American Pharmacists Association Foundation. In 2015, Knowlton was awarded the Remington Honor Medal, which is pharmacy’s highest honor.

Board service includes: Chair of the Board of the Evergreens Continuing Care Retirement Community; Founding Board member of the Cooper Medical School of Rowan University; member of the Boards for The Coriell Institute for Medical Research, St Christopher’s Hospital for Children and the Settlement Music School.

Knowlton is the co-Founder, Chairperson and CEO of Tabula Rasa HealthCare (TRHC), which is the first national Medication Risk Mitigation™ company. Since its founding in 2009, TRHC has become the leader in providing patient-specific, data-driven technology and solutions that enable health care organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower health care costs and manage risk. He took TRHC public in September, 2016 (NASDAQ: TRHC).

Knowlton received his pharmacy degree from Temple University, his Divinity degree from Princeton Theological Seminary, and his PhD in pharmacoeconomics from the University of Maryland. He served as Professor and Department Chair for the University of the Sciences in Philadelphia in the 1990s.

    Minnesota Pharmacists Association

     

    1000 Westgate Drive, Suite 252, St. Paul, MN 55114 | Phone: 651.697.1771 Fax: 650.290.2266 Email: info@mpha.org

    © 2019 MPhA. All Rights Reserved. Site Map. Email Deliverability.